Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial.
Goeldlin MB, Hakim A, Branca M, Abend S, Kneihsl M, Valenzuela Pinilla W, Fenzl S, Rezny-Kasprzak B, Rohner R, Strbian D, Paciaroni M, Thomalla G, Michel P, Nedeltchev K, Gattringer T, Sandset EC, Bonati L, Aguiar de Sousa D, Sylaja PN, Ntaios G, Koga M, Gdovinova Z, Lemmens R, Bornstein NM, Kelly P, Katan M, Horvath T, Dawson J, Fischer U; ELAN Investigators. Goeldlin MB, et al. JAMA Neurol. 2024 Jul 1;81(7):693-702. doi: 10.1001/jamaneurol.2024.1450. JAMA Neurol. 2024. PMID: 38805207 Clinical Trial.
Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN Trial.
Rohner R, Kneihsl M, Goeldlin MB, Hakim A, Branca M, Abend S, Valenzuela Pinilla W, Fenzl S, Rezny-Kasprzak B, Strbian D, Trelle S, Paciaroni M, Thomalla G, Michel P, Nedeltchev K, Gattringer T, Sandset EC, Bonati L, Aguiar de Sousa D, Sylaja PN, Ntaios G, Koga M, Gdovinova Z, Lemmens R, Bornstein NM, Kelly P, Katan M, Horvath T, Dawson J, Fischer U; ELAN Investigators. Rohner R, et al. Among authors: goeldlin mb. Circulation. 2024 Jul 2;150(1):19-29. doi: 10.1161/CIRCULATIONAHA.124.069324. Epub 2024 May 16. Circulation. 2024. PMID: 38753452 Free article. Clinical Trial.
Intravenous thrombolysis in patients with recent intake of direct oral anticoagulants: A target trial analysis after the liberalization of institutional guidelines.
Bücke P, Jung S, Kaesmacher J, Goeldlin MB, Horvath T, Prange U, Beyeler M, Fischer U, Arnold M, Seiffge DJ, Meinel TR. Bücke P, et al. Among authors: goeldlin mb. Eur Stroke J. 2024 May 13:23969873241252751. doi: 10.1177/23969873241252751. Online ahead of print. Eur Stroke J. 2024. PMID: 38738861 Free article.
Baseline characteristics and outcome of stroke patients after endovascular therapy according to previous symptomatic vascular disease and sex.
Peycheva M, Padlina G, Genceviciute K, Krasteva MP, Boronylo A, Goeldlin MB, Müller M, Wenz ES, Müller MD, Hammer H, Bücke P, Bigi S, Simonetti BG, Hoffmann A, Umarova RM, Pilgram-Pastor S, Gralla J, Mordasini P, Antonenko K, Heldner MR. Peycheva M, et al. Among authors: goeldlin mb. Front Neurol. 2024 Apr 17;15:1293905. doi: 10.3389/fneur.2024.1293905. eCollection 2024. Front Neurol. 2024. PMID: 38694775 Free PMC article.
Intracerebral haemorrhage in patients taking different types of oral anticoagulants: a pooled individual patient data analysis from two national stroke registries.
Siepen BM, Forfang E, Branca M, Drop B, Mueller M, Goeldlin MB, Katan M, Michel P, Cereda C, Medlin F, Peters N, Renaud S, Niederhauser J, Carrera E, Kahles T, Kägi G, Bolognese M, Salmen S, Mono ML, Polymeris AA, Wegener S, Z'Graggen W, Kaesmacher J, Schaerer M, Rodic B, Kristoffersen ES, Larsen KT, Wyller TB, Volbers B, Meinel TR, Arnold M, Engelter ST, Bonati LH, Fischer U, Rønning OM, Seiffge DJ. Siepen BM, et al. Among authors: goeldlin mb. Stroke Vasc Neurol. 2024 Feb 8:svn-2023-002813. doi: 10.1136/svn-2023-002813. Online ahead of print. Stroke Vasc Neurol. 2024. PMID: 38336370 Free article.
Andexanet alfa versus non-specific treatments for intracerebral hemorrhage in patients taking factor Xa inhibitors - Individual patient data analysis of ANNEXA-4 and TICH-NOAC.
Siepen BM, Polymeris A, Shoamanesh A, Connolly S, Steiner T, Poli S, Lemmens R, Goeldlin MB, Müller M, Branca M, Rauch J, Meinel T, Kaesmacher J, Z'Graggen W, Arnold M, Fischer U, Peters N, Engelter ST, Lyrer P, Seiffge D. Siepen BM, et al. Among authors: goeldlin mb. Int J Stroke. 2024 Jun;19(5):506-514. doi: 10.1177/17474930241230209. Epub 2024 Mar 8. Int J Stroke. 2024. PMID: 38264861
Time for "code ICH"? - Workflow metrics of hyperacute treatments and outcome in patients with intracerebral haemorrhage.
Bettschen E, Siepen BM, Goeldlin MB, Mueller M, Buecke P, Prange U, Meinel TR, Drop BRH, Bervini D, Dobrocky T, Kaesmacher J, Exadaktylos AK, Sauter TC, Volbers B, Arnold M, Jung S, Fischer U, Z'Graggen W, Seiffge D. Bettschen E, et al. Among authors: goeldlin mb. Cerebrovasc Dis. 2024 Jan 10. doi: 10.1159/000536099. Online ahead of print. Cerebrovasc Dis. 2024. PMID: 38198772 Free article.
CADMUS: A Novel MRI-Based Classification of Spontaneous Intracerebral Hemorrhage Associated With Cerebral Small Vessel Disease.
Goeldlin MB, Mueller M, Siepen BM, Zhang W, Ozkan H, Locatelli M, Du Y, Valenzuela W, Radojewski P, Hakim A, Kaesmacher J, Meinel TR, Clénin L, Branca M, Strambo D, Fischer T, Medlin F, Peters N, Carrera E, Lovblad KO, Karwacki GM, Cereda CW, Niederhauser J, Mono ML, Mueller A, Wegener S, Sartoretti S, Polymeris AA, Altersberger V, Katan M, Psychogios M, Sturzenegger R, Nauer C, Schaerer M, Buitrago Tellez C, Renaud S, Minkner Klahre K, Z'Graggen WJ, Bervini D, Bonati LH, Wiest R, Arnold M, Simister RJ, Wilson D, Jäger HR, Fischer U, Werring DJ, Seiffge DJ; for Swiss Stroke Registry Investigators and SIGNAL Investigators. Goeldlin MB, et al. Neurology. 2024 Jan 9;102(1):e207977. doi: 10.1212/WNL.0000000000207977. Epub 2023 Dec 15. Neurology. 2024. PMID: 38165372 Free PMC article.
Clinical Associations and Prognostic Value of MRI-Visible Perivascular Spaces in Patients With Ischemic Stroke or TIA: A Pooled Analysis.
Best JG, Ambler G, Wilson D, Du H, Lee KJ, Lim JS, Teo KC, Mak H, Kim YD, Song TJ, Selcuk Demirelli D, Nishihara M, Yoshikawa M, Kubacka M, Zietz A, Al-Shahi Salman R, Jäger HR, Lip GYH, Panos L, Goeldlin MB, Slater LA, Karayiannis CC, Phan TG, Bellut M, Abrigo J, Cheng C, Leung TW, Chu W, Chappell F, Makin SDJ, van Dam-Nolen DHK, Kooi ME, Köhler S, Staals J, Kuchcinski G, Bordet R, Dubost F, Wardlaw JM, Soo YOY, Fluri F, Srikanth VK, Jung S, Peters N, Hara H, Yakushiji Y, Necioglu Orken D, Heo JH, Lau GKK, Bae HJ, Werring DJ. Best JG, et al. Among authors: goeldlin mb. Neurology. 2024 Jan 9;102(1):e207795. doi: 10.1212/WNL.0000000000207795. Epub 2023 Dec 13. Neurology. 2024. PMID: 38165371 Free PMC article.
Geographical Requirements for the Applicability of the Results of the RACECAT Study to Other Stroke Networks.
Schuler FAF, Ribó M, Dequatre-Ponchelle N, Rémi J, Dobrocky T, Goeldlin MB, Gralla J, Kaesmacher J, Meinel TR, Mordasini P, Seiffge DJ, Fischer U, Arnold M, Kägi G, Jung S. Schuler FAF, et al. Among authors: goeldlin mb. J Am Heart Assoc. 2023 Oct 17;12(20):e029965. doi: 10.1161/JAHA.123.029965. Epub 2023 Oct 13. J Am Heart Assoc. 2023. PMID: 37830330 Free PMC article.
20 results